Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Interim Management Statement

24 Apr 2009 07:00

RNS Number : 0884R
Stanelco PLC
24 April 2009
 



24 April 2009

Stanelco plc ("the Company" or "the Group")

Interim Management Statement

Stanelco plc, which is holding its 2009 Annual General Meeting at 10.30am today, issues its interim management statement for the period from 1 January 2009 to 23 April 2009, as required by the UK Listing Authority's Disclosure and Transparency Rules.

 

The 2009 financial year has started well and trading during the first quarter to 31 March 2009 was in line with the Board's expectations.

In the quarter the Group achieved double digit revenue growth in sales of bioplastics made directly by the Company. The Group also achieved double digit growth in its RF Applications division as we continued to broaden our RF product offering.

A slightly slower start to the year led to third party sales from our joint venture, Biotec, being 2% down in the quarter compared with the same period last year. However by the end of the quarter sales had returned to previous levels and are now showing an upward trend.

Overall, Group revenues increased in the quarter to £3.5m (Q1 2008: £3.4m). 

We continue to work closely with our customer base in the BioPlastics division, carefully developing products that will meet their specific requirements and will, in time, be suitable for volume commercialisation. The wide experience of the technical team we have put in place and the close support of the pilot facility in Southampton are proving invaluable in this respect.

In the RF Applications division, where our main focus has been on widening our product range, we have received a number of orders in the quarter for products introduced last year for the induction heating market and continue to see significant interest in our range of furnaces, particularly from customers in the Far East.

The Board's focus for this year continues to be on cash control and generating profitability from our operations. At 31 March 2009 we had cash of £5.5m and we continue to consider sensible investment opportunities to accelerate our growth.

- Ends -

For further information please contact:

Paul Mines, Chief Executive, Stanelco plc

Sue Bygrave, Group Finance Director, Stanelco plc

Tel: +44 (0) 2380 867100

Jonathon Brill/Caroline Stewart

Financial Dynamics

Tel: +44 (0) 20 7831 3113

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSIJMRTMMMTBAL
Date   Source Headline
15th May 20067:01 amRNSAppointment of Adviser
3rd May 20061:05 pmRNSNotifiable Interest
2nd May 20064:58 pmRNSResult of AGM
2nd May 20062:00 pmRNSAGM Statement
10th Apr 20063:12 pmRNSAnnual Report and Accounts
7th Apr 20062:46 pmRNSAdditional Listing
13th Mar 20067:02 amRNSDirectorate Change
28th Feb 20067:02 amRNSPreliminary Results
24th Feb 20067:02 amRNSCooperation with Wal-Mart
14th Feb 20069:07 amRNSAdditional Listing
14th Feb 20067:00 amRNSUS FDA approval for Starpol
9th Feb 200610:42 amRNSIsraCaps new licence terms
9th Feb 20067:02 amRNSRe: BioProgress plc
16th Dec 20057:01 amRNSFunding for R&D facility
16th Dec 20057:01 amRNSPre Close Update
14th Dec 20057:01 amRNSLandmark deal with Perseco
8th Dec 200510:25 amRNSShare Listing Application
30th Nov 20055:40 pmRNSDirectorate Change
28th Nov 20059:24 amRNSBoard Changes
8th Nov 20057:01 amRNSPatent sale process update
3rd Nov 20054:47 pmRNSExercise of Options
1st Nov 20057:02 amRNSChange of Adviser
12th Oct 20057:00 amRNSApproval of Starpol
3rd Oct 20057:00 amRNSPatent Disposal & Update
22nd Sep 20057:02 amRNSRe Agreement
12th Sep 20057:03 amRNSDevelopment of capsule
5th Sep 20057:03 amRNSRe: Completion
30th Aug 20053:30 pmRNSDoc re. Result of EGM
30th Aug 200511:08 amRNSEGM Statement
30th Aug 20057:03 amRNSRe Agreement
5th Aug 200511:15 amRNSRe posting of circular
1st Aug 20057:01 amRNSDirector Appointment
28th Jul 20057:01 amRNSUpdate re: trials with ASDA
26th Jul 20057:00 amRNSContract Win
19th Jul 20057:00 amRNSRe Agreement
5th Jul 20057:01 amRNSRe Joint Venture
29th Jun 20057:00 amRNSInterim Results
22nd Jun 20057:00 amRNSUpdate re trials with Asda
8th Jun 20055:29 pmRNSAdditional Listing
8th Jun 200510:00 amRNSAppointment of Group MD
8th Jun 20057:50 amRNSPlacing of Ordinary Shares
6th Jun 20057:01 amRNSAcquisition
3rd Jun 20053:02 pmRNSIssue of Equity
23rd May 20057:01 amRNSRe Contract
17th May 200512:12 pmRNSAdditional Listing
10th May 20057:00 amRNSUpdate re. trials with Asda
29th Apr 20053:46 pmRNSHolding(s) in Company
25th Apr 20053:27 pmRNSDirector Shareholding
22nd Apr 20052:24 pmRNSResult of AGM
22nd Apr 200511:31 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.